Viewing Study NCT01056159


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2026-01-25 @ 12:22 PM
Study NCT ID: NCT01056159
Status: COMPLETED
Last Update Posted: 2022-02-02
First Post: 2010-01-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None asthma View
None dry powder inhaler View
None short-acting beta2-agonist View
None SABA View
None bronchoconstriction View
None bronchodilation View
None bronchodilator View
None metered dose inhaler View